Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven cases.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
05 Sep 2022
Historique:
received: 10 05 2022
revised: 23 06 2022
accepted: 29 08 2022
pubmed: 1 9 2022
medline: 17 9 2022
entrez: 31 8 2022
Statut: ppublish

Résumé

Fusarium spp. are plant pathogens and opportunistic pathogens in severely immunocompromised (hematological malignancy, neutropenia, solid organ transplantation, etc.) and severely burned patients. Invasive fusariosis often disseminates and mortality remains high partly due to delayed diagnosis in the absence of a positive culture. The aim of our study is to design a quantitative PCR (qPCR) assay and evaluate the detection of Fusarium spp. DNA for early diagnosis of invasive infection. A qPCR assay was designed and optimized to identify all Fusarium species complex and secondarily evaluated on patient samples. A total of 81 blood samples from 15 patients diagnosed with proven invasive fusariosis from 9 centers in France were retrospectively tested. Circulating DNA was detected in 14 patients out of 15 (sensitivity of 93% [95% Confidence Interval (CI95), 70.1-99.7]). Detection was possible up to 18 days (median 6 days) before the diagnosis was confirmed by positive blood culture or biopsy. By comparison serum galactomannan and ß-D-glucan were positive in 7.1 and 58.3% of patients respectively. qPCR was negative for all patients with other invasive fungal diseases (IFD) tested (n = 12) and IFD-free control patients (n = 40). No cross-reactions were detected using DNA extracted from 81 other opportunistic fungi. We developed and validated a pan-Fusarium qPCR assay in serum/plasma with high sensitivity, specificity, and reproducibility that could facilitate early diagnosis and treatment monitoring of invasive fusariosis. Fusariosis ranks third among invasive mould infections. It is frequently diagnosed late due to the lack of specific tools. We designed and evaluated a new qPCR assay with high sensitivity and specificity allowing detection of Fusarium DNA in serum samples up to 18 days before conventional diagnosis.

Identifiants

pubmed: 36044994
pii: 6679565
doi: 10.1093/mmy/myac049
pii:
doi:

Substances chimiques

Antifungal Agents 0
Cell-Free Nucleic Acids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Sarah Dellière (S)

Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Louis, F-75010 Paris, France.
Institut Pasteur, Université de Paris Cité, CNRS, Unité de Mycologie Moléculaire, UMR2000, F-75015 Paris, France.

Juliette Guitard (J)

Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-Antoine, Service de Parasitologie-Mycologie, F-75012 Paris, France.

Marcela Sabou (M)

Laboratoire de Parasitologie et de Mycologie Médicale, Hôpitaux Universitaires de Strasbourg, F-67000 Strasbourg, France.
Institut de Parasitologie et de Pathologie Tropicale, UR7292 Dynamique des Interactions Hôte Pathogène, Fédération de Médecine Translationnelle, Université de Strasbourg, F-67000 Strasbourg, France.

Cécile Angebault (C)

Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Henri Mondor, UR Dynamyc UPEC, EnVA, ANSES, F-94010 Créteil, France.

Maxime Moniot (M)

Service de Parasitologie-Mycologie, CHU Clermont-Ferrand, 3IHP, F-63000 Clermont-Ferrand, France.

Marjorie Cornu (M)

Inserm U1285, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Univ. Lille, F-59000, Lille, France.
Laboratoire de Prasitologie-Mycologie, CHU Lille, F-59000, Lille, France.

Samia Hamane (S)

Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Louis, F-75010 Paris, France.

Marie-Elisabeth Bougnoux (ME)

CHU Necker Enfants Malades, AP-HP, Institut Pasteur, F-75015 Paris, France.

Sébastien Imbert (S)

Laboratoire de Parasitologie-Mycologie, Bordeaux University Hospital, F-33000 Bordeaux, France.

Grégoire Pasquier (G)

University of Montpellier, CNRS, IRD, Academic Hospital (CHU) of Montpellier, MiVEGEC, F-34295 Montpellier, France.

Françoise Botterel (F)

Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Henri Mondor, UR Dynamyc UPEC, EnVA, ANSES, F-94010 Créteil, France.

Dea Garcia-Hermoso (D)

Institut Pasteur, Université de Paris Cité, CNRS, Unité de Mycologie Moléculaire, UMR2000, F-75015 Paris, France.
Institut Pasteur, Centre National de Référence Mycologie et Antifongiques, F-75015 Paris, France.

Alexandre Alanio (A)

Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Louis, F-75010 Paris, France.
Institut Pasteur, Université de Paris Cité, CNRS, Unité de Mycologie Moléculaire, UMR2000, F-75015 Paris, France.
Institut Pasteur, Centre National de Référence Mycologie et Antifongiques, F-75015 Paris, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

Classifications MeSH